Drug Development and Technology
FEB 14, 2017
DelMar Pharma begins dosing in Phase II trial of VAL-083 to treat GBM
Rare Disease Report
FEB 13, 2017
Phase II Glioblastoma Multiforme Trial Underway
Drug Development and Delivery Magazine July/Aug 2016
JUL 1, 2016
Interview with Del Mar Pharmaceuticals' Chairman & CEO
MicroCap Review Magazine Winter/Spring 2016
JAN 19, 2016
Profiled Company: DelMar Pharmaceuticals, Inc. OTCQX: DMPI
SEP 22, 2015
Profile of DelMar Pharmacueticals
Pharmacuetical Processing
AUG 24, 2015
Big Pharma Presenting Significant Findings
Wall Street Analyzer
JUL 30, 2015
DelMar Pharmaceuticals (OTCQX:DMPI) CEO Interview
Drug Discovery & Development
JUL 20, 2015
DelMar Expands GBM Clinical Trial with 5th Site in Denver
MAY 29, 2015
VAL-083 AACR data
Bio Century
MAY 4, 2015
VAL-083 phase I/II data
Drug Delivery News Daily
APR 22, 2015
Coverage of ASCO clinical data release
Drug Delivery News Daily
APR 22, 2015
Newsletter coverage of ASCO clinical data release
FEB 26, 2015
Q&A with Jeff Bacha on company and VAL-083
FEB 26, 2015
Feature on DelMar's VAL-083
Cancer Therapy Advisor
JAN 13, 2015
Feature on VAL-083
BioPharma Insights
JAN 1, 2015
Feature on VAL-083